Saltar al contenido principal

Sample Outputs and Deliverables

This page shows the concrete outputs that sponsors, CROs, and investigators receive from each acne severity assessment. The AI generates standardised reports immediately after image submission — no central reader, no delays.

Per-visit assessment report

Each image submission generates a complete severity report, accessible to the investigator within seconds:

Acne Lesion And Density INdex

Score: 3.5

Report Information

Timestamp

3/27/2026, 10:17:03 PM

Analysis performed in

1.2 seconds

Status

Not reviewed

Analyzed Left diagonal

Body site

Left diagonal

p]:mb-0>

Image quality

92%

p]:mb-0>

Lesion count

36

p]:mb-0>

Density

0.55

p]:mb-0>

Local score

3.42

Analyzed Right diagonal

Body site

Right diagonal

p]:mb-0>

Image quality

88%

p]:mb-0>

Lesion count

35

p]:mb-0>

Density

0.6

p]:mb-0>

Local score

3.49

What the report contains

OutputDetail
Global IGA score0–4 integer aligned with the FDA co-primary endpoint
Global ALADIN score0–10 continuous composite (IGA × 2.5), for secondary/exploratory use
Per-perspective lesion countIndividual inflammatory lesion count (papules, pustules, nodules) per half-face
Per-perspective densitySpatial density ratio (0–1) measuring lesion clustering
Per-perspective local IGALocal severity score for each captured perspective
Annotated imagesEach perspective with bounding boxes around detected inflammatory lesions
Image quality (DIQA)Quality score per image; images below threshold are flagged for recapture
TimestampUTC timestamp of image capture and AI processing
Why annotated images matter

The bounding box overlays allow investigators to visually verify the AI's detections against their clinical observation. This audit trail supports regulatory inspection and gives sites confidence in what the system produces.

Longitudinal severity tracking

Across visits, the platform tracks severity evolution from screening to end of study:

Severity chart

What longitudinal tracking delivers

  • Score trajectory: IGA and ALADIN at every visit, from screening to end of study
  • Treatment response flag: IGA ≥ 2-grade improvement from baseline (configurable threshold)
  • Absolute change: Point change in IGA and ALADIN vs. baseline at each visit
  • Visual chart: Graphical severity curve across all timepoints

This enables investigators and sponsors to identify responders and non-responders during the trial — not just at database lock.

Data export for EDC integration

All assessment outputs are structured for export to the sponsor's EDC system. Fields exported at each visit:

FieldDescriptionFormat
Patient identifierStudy-specific pseudonymised IDString
Visit dateDate and timestamp of the assessmentISO 8601
Global IGA scoreIGA severity (0–4)Integer
Global ALADIN scoreComposite severity (0–10)Float
Global lesion countTotal inflammatory lesions (deduplicated across perspectives)Integer
Per-perspective IGALocal IGA score for each perspectiveInteger
Per-perspective lesion countLesions detected per perspectiveInteger
Per-perspective densitySpatial density per perspectiveFloat (0–1)
DIQA scoresImage quality score per perspectiveFloat
Severity classificationClear / Almost clear / Mild / Moderate / SevereString

Data is transferred automatically via RESTful API or scheduled S3 export. Formats include structured JSON and CSV/Excel. Legit.Health provides IQ/OQ documentation and data mapping specifications.

AI visual outputs

Beyond scores, the AI produces visual artefacts that demonstrate exactly what the system detected and how it reached its conclusion. These are available in every per-visit report.

Lesion detection with bounding boxes

Each inflammatory lesion (papule, pustule, nodule) is identified and highlighted with a bounding box overlay on the original photograph. Investigators can verify the AI's detections at a glance.

Original photograph

Input: standardised facial photograph

Bounding box overlay

Output: each detected inflammatory lesion highlighted

Facial landmark detection and pose estimation

The AI maps facial landmarks (eyes, nose, mouth, jawline) to identify the capture perspective, define region boundaries, and deduplicate lesions across overlapping perspectives.

Landmark mesh overlay

Facial landmark mesh with region boundaries

Region exclusion mask

Perspective-specific exclusion zone for lesion deduplication

Anonymization

All photographs are processed with automatic face anonymization. The system detects facial features and applies irreversible blurring to ensure no patient is identifiable from the stored or exported images.

Before anonymization

Original capture (eyes, nose, mouth visible)

After anonymization

Irreversible face blurring applied

Reliability of the scores

The ALADIN scoring system achieves Cohen's κ = 0.53 against the dermatologist consensus — matching or exceeding the typical inter-rater agreement of individual expert dermatologists (κ = 0.46). This means the AI is at least as consistent a rater as adding a board-certified dermatologist to the panel.

Critically, unlike a human rater, the AI produces the identical score for the same image every time, across every site, without calibration drift or fatigue. There is zero intra-rater variability.

For the full validation evidence: Clinical Evidence →